Načítá se...
TAK1 deficiency attenuates cisplatin-induced acute kidney injury
Cisplatin can cause acute kidney injury (AKI), but the molecular mechanisms are not well understood. The objective of the present study was to examine the role of transforming growth factor-β-activated kinase-1 (TAK1) in the pathogenesis of cisplatin-induced AKI. Wild-type mice and proximal tubule T...
Uloženo v:
| Vydáno v: | Am J Physiol Renal Physiol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985823/ https://ncbi.nlm.nih.gov/pubmed/31813254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00516.2019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|